- RON1.27bn
- RON1.10bn
- RON319.33m
Annual income statement for Biofarm SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 239 | 277 | 280 | 287 | 319 |
| Cost of Revenue | |||||
| Gross Profit | 198 | 231 | 231 | 239 | 273 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 170 | 199 | 203 | 209 | 213 |
| Operating Profit | 68.7 | 77.7 | 76.8 | 78.1 | 106 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 69.6 | 80.9 | 83.7 | 84.5 | 115 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 60.4 | 70.9 | 77 | 74.4 | 101 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 60.4 | 70.9 | 77 | 74.4 | 101 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 60.4 | 70.9 | 77 | 74.4 | 101 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.061 | 0.073 | 0.078 | 0.076 | 0.102 |
| Dividends per Share |